Stock Analysis

KRX Growth Leaders With Insider Ownership Up To 38%

Published

The South Korean stock market has shown resilience, bouncing back with gains across various sectors after a brief pause in its upward trajectory. As the KOSPI hovers around the 2,860-point mark, investor optimism is palpable, influenced by global economic cues and interest rate outlooks. In such an environment, growth companies with high insider ownership can be particularly compelling as they often signal confidence from those who know the company best—its insiders.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
ALTEOGEN (KOSDAQ:A196170)26.6%73.1%
Seojin SystemLtd (KOSDAQ:A178320)29.8%58.7%
Global Tax Free (KOSDAQ:A204620)18.1%72.4%
Fine M-TecLTD (KOSDAQ:A441270)17.3%36.4%
Park Systems (KOSDAQ:A140860)33%35.6%
Vuno (KOSDAQ:A338220)19.5%105%
UTI (KOSDAQ:A179900)34.1%122.7%
HANA Micron (KOSDAQ:A067310)20%96.3%
INTEKPLUS (KOSDAQ:A064290)16.3%77.4%
Techwing (KOSDAQ:A089030)18.7%77.8%

Click here to see the full list of 80 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

EO Technics (KOSDAQ:A039030)

Simply Wall St Growth Rating: ★★★★★☆

Overview: EO Technics Co., Ltd. is a global manufacturer and supplier of laser processing equipment, with a market capitalization of approximately ₩2.54 billion.

Operations: The company's revenue primarily comes from its Semiconductor Machine Division, generating ₩305.34 billion.

Insider Ownership: 30.7%

EO Technics, a South Korean company with high insider ownership, shows promising growth prospects with expected annual revenue and earnings growth rates at 25.2% and 48.3% respectively, outpacing the national market averages. However, challenges include a forecasted low Return on Equity of 15.9% in three years and recent volatility in share price. Notably, there's no significant insider trading activity reported over the past three months, and profit margins have declined from last year’s 16.4% to 11%.

KOSDAQ:A039030 Ownership Breakdown as at Jul 2024

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biopharmaceutical company engaged in developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market capitalization of approximately ₩14.80 billion.

Operations: The company generates revenue through the development of enhanced biologics, targeted cancer therapies, and similar versions of existing antibody treatments.

Insider Ownership: 26.6%

ALTEOGEN, a South Korean biotech firm, is poised for significant growth with earnings expected to increase by 73.1% annually, outperforming the local market forecast of 29.7%. Despite trading at 71.9% below its estimated fair value and experiencing high share price volatility recently, the company became profitable this year and maintains a very high forecasted Return on Equity of 45.3%. Recent developments include the MFDS approval of Tergase®, enhancing its commercial potential despite shareholder dilution over the past year.

KOSDAQ:A196170 Earnings and Revenue Growth as at Jul 2024

Doosan (KOSE:A000150)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Doosan Corporation operates in heavy industry, machinery manufacturing, and apartment construction across various global regions including South Korea, the United States, Asia, the Middle East, and Europe with a market capitalization of approximately ₩3.81 billion.

Operations: Doosan's revenue is primarily generated from Doosan Bobcat and Doosan Energy, contributing ₩9.75 billion and ₩8.27 billion respectively, followed by smaller contributions from Electronic BG at ₩0.83 billion, Digital Innovation BU at ₩0.28 billion, and Doosan Fuel Cell at ₩0.24 billion.

Insider Ownership: 38.9%

Doosan Corporation, a South Korean conglomerate, is transitioning towards profitability with expectations to turn a profit within the next three years. Despite slower revenue growth at 3.5% annually compared to the broader market's 10.8%, its earnings are projected to surge by 72.88% per year. The firm's recent financial recovery is evident from its Q1 results in 2024, showing substantial improvements in sales and net income, moving from a significant loss last year to a profit this year.

KOSE:A000150 Ownership Breakdown as at Jul 2024

Taking Advantage

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're helping make it simple.

Find out whether EO Technics is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com